Life ScienceCompany
Bristol-Myers Squibb - Drug Product Manufacturing Facility Ownership
Who owns Bristol-Myers Squibb - Drug Product Manufacturing Facility?
Bristol-Myers Squibb - Drug Product Manufacturing Facility is owned by STA Pharmaceutical. It was acquired on August 3, 2021.
Bristol-Myers Squibb - Drug Product Manufacturing Facility Business Overview
Where is Bristol-Myers Squibb - Drug Product Manufacturing Facility headquartered?
Bristol-Myers Squibb - Drug Product Manufacturing Facility is headquartered in Couvet, Switzerland.
What sector is Bristol-Myers Squibb - Drug Product Manufacturing Facility in?
Bristol-Myers Squibb - Drug Product Manufacturing Facility is a life science company.
When was Bristol-Myers Squibb - Drug Product Manufacturing Facility founded?
Bristol-Myers Squibb - Drug Product Manufacturing Facility was founded in 2018.
Life Science M&A Summary in 2021
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.
Join Mergr to view all 397 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 351 by strategics.